Amazon cover image
Image from Amazon.com

Pharmaceutical dosage forms and drug delivery systems / Howard C. Ansel, Loyd V. Allen, Jr., Nicholas G. Popovich.

By: Contributor(s): Publication details: Philadelphia, Pa. : Lippincott-Williams & Wilkins, c1999.Edition: 7th editionDescription: x, 595 p. : ill. ; 26 cmISBN:
  • 0683305727
  • 9780683305722
Subject(s): NLM classification:
  • QV 785 A618i 1999
Contents:
Contents Section 1 Principles of dosage form design and development 1.Introduction to drugs and pharmacy 2.New drug development and approval process 3.Dosage form design - pharmaceutic and formulation consideration 4.Dosage form design - biopharmaceutic and pharmacokinetics considerations 5.Current good manufacturing practices and good compounding practices. Section 2 Solid dosage forms and modified-release drug delivery systems 6.Powders and granules 7.Capsules and tables 8.Modified-release dosage forms and drug delivery systems. section 3 Semi-solid and transdermal systems 9Ointments, creams, and gels 10.Transdermal drug delivery systems Section 4 Pharmaceutical inserts 11.Suppositories and inserts. Section 5 Liquid dosage forms 12.Solutions 13.Disperse systems. Section 6 Sterile dosage forms and delivery systems 14.Parenteral 15.Biological 16.Ophthalmic solutions and suspensions. Section 7 Novel and advanced dosage forms, delivery systems, and devices 17.Radiopharmaceuticals 18.Products of biotechnology 19.Novel dosage forms and drug delivery technology. Appendix: systems and techniques of pharmaceutical measurement.
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
Holdings
Item type Current library Call number Copy number Status Date due Barcode
Book Open Access Book Open Access Health Sciences Library QV 785 A618i 1999 (Browse shelf(Opens below)) 1 Available MBAL22020915

Includes bibliographical references and index.

Contents

Section 1 Principles of dosage form design and development
1.Introduction to drugs and pharmacy
2.New drug development and approval process
3.Dosage form design - pharmaceutic and formulation consideration
4.Dosage form design - biopharmaceutic and pharmacokinetics considerations
5.Current good manufacturing practices and good compounding practices.

Section 2 Solid dosage forms and modified-release drug delivery systems
6.Powders and granules
7.Capsules and tables
8.Modified-release dosage forms and drug delivery systems.

section 3 Semi-solid and transdermal systems
9Ointments, creams, and gels
10.Transdermal drug delivery systems

Section 4 Pharmaceutical inserts
11.Suppositories and inserts.

Section 5 Liquid dosage forms
12.Solutions
13.Disperse systems.

Section 6 Sterile dosage forms and delivery systems
14.Parenteral
15.Biological
16.Ophthalmic solutions and suspensions.

Section 7 Novel and advanced dosage forms, delivery systems, and devices
17.Radiopharmaceuticals
18.Products of biotechnology
19.Novel dosage forms and drug delivery technology.

Appendix: systems and techniques of pharmaceutical measurement.

There are no comments on this title.

to post a comment.